New Study Reveals Mechanism Behind Persistent HIV Traces Post-Treatment
Study explains why HIV sometimes persists in blood post-treatment
Johns Hopkins University
Image: Johns Hopkins University
A recent study published in Nature Communications explains why some individuals on antiretroviral therapy still show detectable HIV levels. The research indicates that these cases are primarily due to defective viral copies, alleviating concerns about transmission and viral rebound for those on treatment.
- 01The study involved 52 participants, primarily white men aged 58-68, from the U.S., Canada, and Denmark.
- 02Around 95% of detectable HIV-1 RNA in participants was due to defective copies caused by mutations in the 5'-leader region.
- 03The new assay, CLAWS, can identify defective viral copies, potentially reducing unnecessary treatments and costs for patients.
- 04This research could enable patients to access surgeries and clinical trials by confirming their HIV is under control.
- 05The study highlights that while intact proviruses are eliminated over time, defective ones persist, prompting further investigation into immune response differences.
Advertisement
In-Article Ad
A study published in Nature Communications has shed light on why some individuals with HIV on antiretroviral therapy experience non-suppressible viremia, or detectable viral loads. Conducted with 52 participants, the research found that approximately 95% of the detectable HIV-1 RNA was due to defective copies of the virus, specifically linked to mutations in the 5'-leader region of the RNA. This discovery is significant as it alleviates fears among patients regarding viral rebound and transmission risks. The study's senior author, Francesco R. Simonetti, emphasized that understanding these defective copies could eliminate the need for additional medications and reduce healthcare costs. Furthermore, the newly developed assay, known as CLAWS (Capturing 5′ Leader Anomalies Without Sequencing), offers a cost-effective method for clinics to confirm the presence of these defective viral copies. This advancement may facilitate patients' access to necessary medical procedures and clinical trials, ensuring they can manage their HIV effectively without unnecessary complications.
Advertisement
In-Article Ad
The findings could significantly reduce unnecessary healthcare costs and improve the quality of life for HIV patients by confirming their viral control status.
Advertisement
In-Article Ad
Reader Poll
What do you think about the implications of this HIV research?
Connecting to poll...
More about Johns Hopkins University
Tod Machover Honored with George Peabody Medal for Music Innovations
Massachusetts Institute Of Technology • Jun 4, 2026
Farmaci oncologici cinesi: opportunità e incertezze nel mondo della ricerca
La Repubblica • Jun 3, 2026
New Study Challenges Mendel's Laws with Discovery of Non-Mendelian Inheritance in Mice
Science Daily • Jun 1, 2026
Read the original article
Visit the source for the complete story.